FDA Announces Environmental Assessments and Findings of No Significant Impact for 141 New Drug Applications

Summary

The US Food and Drug Administration (FDA) has reviewed environmental assessments and issued findings of no significant impact for 141 new drug applications, abbreviated new drug applications, and supplemental applications, as required by federal regulations.